Market cap was $89 million prior to Allergan buyout. Allergan bought them out two months after NASH Phase 2 study results:
Allergan to Buy Tobira Therapeutics for $1.7 Billion | Fortune
fortune.com › Health › Allergan
Add to My Watchlist
What is My Watchlist?
